Half Yearly Results of Concord Biotech Ltd. (Figures in Rs crores)

	Sep 30, 2026	Mar 31, 2026	Sep 30, 2025	Mar 31, 2025	Sep 30, 2024
Net Sales / Income	572.83	604.03	451.05	674.10	525.98
Other Income	23.55	25.62	27.11	24.11	20.33
Net Profit/Loss	136.91	157.80	105.46	216.03	156.94
Raw Material	133.52	137.13	117.21	141.22	123.09
Power And Fuel	0	29.76	0	55.78	0
Employee Expenses	90.22	89.11	81.08	73.61	65.33
Excise
Admin And Selling Expenses	0	0	0	0	0
Research And Devlopment Expenses	0	0	0	0	0
Expenses Capitalised	0	0	0	0	0
Other Expenses	181.22	144.46	150.40	97.96	151.56
Provisions Made	0	0	0	0	0
Interest	0.03	0.12	0.12	0.19	0.34
Gross Profit	220.51	250.11	178.92	312.30	237.95
Depreciation	36.38	38.16	36.17	27.88	26.49
Taxation	47.22	50.87	37.30	68.39	54.52
Extra Ordinary Item	0	-3.28	0	0	0
Prior Year Adjustments	0	0	0	0	0
Equity Capital	10.46	10.46	10.46	10.46	10.46
Equity Dividend Rate	0	0	0	0	0
Agg.Of Non-Prom. Shares (in lacs)	0	0	0	0	0
Agg.Of Non PromotoHolding (%)	0	0	0	0	0
EPS (in Rs.)	13.09	15.08	10.08	20.65	15

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article